GE HealthCare Technologies Inc. (GEHC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 5,007 | 4,777 | 4,863 | 4,839 |
| Cost of sales-Service | 863 | 802 | 805 | 792 |
| Cost of sales-Product | 2,160 | 1,963 | 2,033 | 2,045 |
| Gross profit | 1,985 | 2,012 | 2,026 | 2,002 |
| Selling, general, and administrative | 1,029 | 1,040 | 1,034 | 1,067 |
| Research and development | 302 | 344 | 316 | 327 |
| Total operating expenses | 1,331 | 1,383 | 1,350 | 1,395 |
| Operating income | 654 | 629 | 676 | 608 |
| Non-operating benefit (income) costs | -73 | -74 | -102 | -101 |
| Interest and other financial charges net | 113 | 110 | 130 | 131 |
| Other (income) expense net | -1 | 99 | 9 | 1 |
| Income before income taxes | 613 | 692 | 658 | 578 |
| Benefit (provision) for income taxes | 113 | 104 | 168 | 143 |
| Net income from continuing operations | - | - | 490 | - |
| Income (loss) from discontinued operations, net of taxes | - | - | - | - |
| Net income | 500 | 588 | 490 | 435 |
| Net (income) loss attributable to noncontrolling interests | 14 | 24 | 19 | 7 |
| Net income attributable to ge healthcare | 486 | 564 | 470 | 428 |
| Deemed preferred stock dividend of redeemable noncontrolling interest | - | - | - | - |
| Net income attributable to ge healthcare common stockholders | - | - | 470 | 428 |
| Basic (in dollars per share) | 1.06 | 1.23 | 1.03 | 0.94 |
| Basic (in shares) | 457,000,000 | 457,000,000 | 457,000,000 | 457,000,000 |
| Diluted (in dollars per share) | 1.06 | 1.23 | 1.02 | 0.93 |
| Diluted (in shares) | 458,000,000 | 459,000,000 | 459,000,000 | 459,000,000 |